ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
CG Oncology Inc

CG Oncology Inc (CGON)

30.245
0.295
( 0.98% )
Updated: 14:08:42

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
30.245
Bid
30.25
Ask
30.30
Volume
475,367
29.54 Day's Range 30.45
25.77 52 Week Range 50.23
Market Cap
Previous Close
29.95
Open
30.02
Last Trade
9
@
30.2561
Last Trade Time
14:08:45
Financial Volume
US$ 14,363,322
VWAP
30.2152
Average Volume (3m)
739,158
Shares Outstanding
67,629,675
Dividend Yield
-
PE Ratio
-30.23
Earnings Per Share (EPS)
-1
Revenue
204k
Net Profit
-67.8M

About CG Oncology Inc

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live ... CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Dover, Delaware, USA
Founded
-
CG Oncology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGON. The last closing price for CG Oncology was US$29.95. Over the last year, CG Oncology shares have traded in a share price range of US$ 25.77 to US$ 50.23.

CG Oncology currently has 67,629,675 shares outstanding. The market capitalization of CG Oncology is US$2.03 billion. CG Oncology has a price to earnings ratio (PE ratio) of -30.23.

CGON Latest News

CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

IRVINE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

CG Oncology Announces Pricing of Public Offering

IRVINE, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

CG Oncology Announces Proposed Public Offering

IRVINE, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

SCHAUMBURG, Ill. and IRVINE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0850.28183023872730.1630.8928.5640814530.00243432CS
4-0.395-1.2891644908630.6431.1627.762755129.80220134CS
12-7.305-19.454061251737.5538.062773915830.64979113CS
260.7452.5254237288129.540.472767355833.90778158CS
52-5.445-15.256374334535.6950.2325.7765152034.87614269CS
1561.2454.293103448282950.2325.7767636334.99451011CS
2601.2454.293103448282950.2325.7767636334.99451011CS

CGON - Frequently Asked Questions (FAQ)

What is the current CG Oncology share price?
The current share price of CG Oncology is US$ 30.245
How many CG Oncology shares are in issue?
CG Oncology has 67,629,675 shares in issue
What is the market cap of CG Oncology?
The market capitalisation of CG Oncology is USD 2.03B
What is the 1 year trading range for CG Oncology share price?
CG Oncology has traded in the range of US$ 25.77 to US$ 50.23 during the past year
What is the PE ratio of CG Oncology?
The price to earnings ratio of CG Oncology is -30.23
What is the cash to sales ratio of CG Oncology?
The cash to sales ratio of CG Oncology is 10.1k
What is the reporting currency for CG Oncology?
CG Oncology reports financial results in USD
What is the latest annual turnover for CG Oncology?
The latest annual turnover of CG Oncology is USD 204k
What is the latest annual profit for CG Oncology?
The latest annual profit of CG Oncology is USD -67.8M
What is the registered address of CG Oncology?
The registered address for CG Oncology is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the CG Oncology website address?
The website address for CG Oncology is cgoncology.com
Which industry sector does CG Oncology operate in?
CG Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RFACURF Acquisition Corporation
US$ 10.12
(96.12%)
12.16k
RFACRF Acquisition Corporation
US$ 10.6299
(76.87%)
988.86k
RNAZTransCode Therapeutics Inc
US$ 9.41
(52.76%)
16.8M
ACBAurora Cannabis Inc
US$ 5.3696
(45.91%)
65.78M
CPIXCumberland Pharmaceutical Inc
US$ 5.3995
(43.60%)
56.66M
VLCNVolcon Inc
US$ 1.8503
(-42.18%)
3.49M
CSAICloudastructure Inc
US$ 8.40
(-35.29%)
207.96k
TCBPTC BioPharm Holdings PLC
US$ 0.2465
(-31.53%)
1.8M
CAPTCaptiVision Inc
US$ 0.72
(-31.43%)
7.91M
UPCUniverse Pharmaceuticals Inc
US$ 0.1863
(-30.97%)
30.41M
CYNCYNGN Inc
US$ 0.085726
(20.74%)
428.88M
RIMEAlgorhythm Holdings Inc
US$ 0.0209
(-14.34%)
216.94M
NVDANVIDIA Corporation
US$ 123.955
(4.47%)
204.63M
ASSTAsset Entities Inc
US$ 0.7698
(40.14%)
165.52M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.052901
(20.78%)
126.31M

Your Recent History

Delayed Upgrade Clock